{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T16:13:44Z","timestamp":1694621624499},"reference-count":34,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2003,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            We compared the activities of telithromycin, erythromycin, azithromycin, josamycin, penicillin G, amoxicillin, cefpodoxime, and ceftriaxone against invasive and noninvasive non-penicillin-susceptible\n            <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n            isolates recovered from children. Of the 186 isolates tested, 89% were positive for\n            <jats:italic>erm<\/jats:italic>\n            (B) by PCR. Telithromycin had the lowest MICs, with MICs at which 90% of the isolates tested are inhibited of 0.032 and 0.25 \u03bcg\/ml for erythromycin-sensitive and -resistant isolates, respectively.\n          <\/jats:p>","DOI":"10.1128\/aac.47.7.2345-2347.2003","type":"journal-article","created":{"date-parts":[[2003,6,23]],"date-time":"2003-06-23T19:17:06Z","timestamp":1056395826000},"page":"2345-2347","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":4,"title":["Activity of Telithromycin against Penicillin-Resistant\n            <i>Streptococcus pneumoniae<\/i>\n            Isolates Recovered from French Children with Invasive and Noninvasive Infections"],"prefix":"10.1128","volume":"47","author":[{"given":"Edouard","family":"Bingen","sequence":"first","affiliation":[{"name":"Service de Microbiologie, Ho\u0302pital Robert Debre\u0301, Paris"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Doit","sequence":"additional","affiliation":[{"name":"Service de Microbiologie, Ho\u0302pital Robert Debre\u0301, Paris"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chawki","family":"Loukil","sequence":"additional","affiliation":[{"name":"Service de Microbiologie, Ho\u0302pital Robert Debre\u0301, Paris"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naima","family":"Brahimi","sequence":"additional","affiliation":[{"name":"Service de Microbiologie, Ho\u0302pital Robert Debre\u0301, Paris"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Bidet","sequence":"additional","affiliation":[{"name":"Service de Microbiologie, Ho\u0302pital Robert Debre\u0301, Paris"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Deforche","sequence":"additional","affiliation":[{"name":"Service de Microbiologie, Ho\u0302pital Robert Debre\u0301, Paris"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Geslin","sequence":"additional","affiliation":[{"name":"Service de Microbiologie, Ho\u0302pital Intercommunal de Cre\u0301teil, Cre\u0301teil, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/PL00011229","volume":"19","year":"2000","unstructured":"Angot, P., M. Vergnaud, M. Auzou, and R. Leclercq. 2000. Macrolide resistance phenotypes and genotypes in French clinical isolates of Streptococcus pneumoniae. Eur. J. Microbiol. Clin. Infect. Dis.19:755-758.","journal-title":"Eur. J. Microbiol. Clin. Infect. Dis."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/340400"},{"key":"e_1_3_1_4_2","unstructured":"Bryskier A. 1999. K\u00e9tolides p. 563-594. In A. Bryskier (ed.) Antibiotiques agents antibact\u00e9riens et antifongiques. Ellipses Marketing S.A. Paris France."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2000.00185.x"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/516284"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.7.1894-1899.2000"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.6.1721-1729.2001"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.6.1480"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.8.2994-2998.2002"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/315502"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf806"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.2.636-638.2001"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1086\/313976"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200106000-00005"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/517384","volume":"177","year":"1998","unstructured":"Guillemot, D., P. Maison, C. Carbon, B. Balkau, F. Vauzelle-Kevro\u00ebdan, C. Sermet, G. Bouvenot, and E. Eschw\u00e8ge. 1998. Trends in antimicrobial drug use in the community-France, 1981-1992. J. Infect. Dis.177:492-497.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/jac\/41.6.649","volume":"41","year":"1998","unstructured":"Hamilton-Miller, J. M., and S. Shah. 1998. Comparative in vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status. J. Antimicrob. Chemother.41:649-653.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.15.1857"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00006454-199611000-00026","volume":"15","year":"1996","unstructured":"Jackson, M. A., V. F. Burry, L. C. Olson, S. E. Duthie, and G. L. Kearns. 1996. Breakthrough sepsis in macrolide-resistant pneumococcal infection. Pediatr. Infect. Dis. J.15:1049-1051.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_1_20_2","first-page":"589","volume":"11","year":"2001","unstructured":"Jacobs, M. R. 2001. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin. Microb. Infect.11:589-596.","journal-title":"Clin. Microb. Infect."},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0924-8579(01)00462-9","volume":"18","year":"2001","unstructured":"Johnson, C. N., W. H. Benjamin, Jr., B. M. Gray, M. C. Crain, K. M. Edward, and K. B. Waites. 2001. In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children. Int. J. Antimicrob. Agents18:531-535.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1086\/318157"},{"key":"e_1_3_1_23_2","first-page":"729","volume":"42","year":"1998","unstructured":"Klugman, K. P., T. Capper, C. A. Widdowson, H. J. Koornhof, and W. Moser. 1998. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. J. Antimicrob. Chemother.42:729-734.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/324626"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.5.1295-1301.2002"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/jac\/45.5.623","volume":"45","year":"2000","unstructured":"Mason, E. O., Jr., L. B. Lamberth, N. L. Kershaw, B. L. Prosser, A. Zoe, and P. G. Ambrose. 2000. Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis. J. Antimicrob. Chemother.45:623-631.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011994"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.9.2427-2431.2001"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.170-175.2001"},{"key":"e_1_3_1_30_2","unstructured":"National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_1_31_2","unstructured":"National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. NCCLS document M100-S12. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.3.624"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/00006454-199512000-00016","volume":"14","year":"1995","unstructured":"Reid, R., J. S. Bradley, and J. Hindler. 1995. Pneumococcal meningitis during therapy of otitis media with clarithromycin. Pediatr. Infect. Dis. J.14:1104-1105.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.11.2562"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf146"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.7.2345-2347.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.7.2345-2347.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:29:30Z","timestamp":1645468170000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.47.7.2345-2347.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1128\/AAC.47.7.2345-2347.2003"],"URL":"https:\/\/doi.org\/10.1128\/aac.47.7.2345-2347.2003","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]},"assertion":[{"value":"2003-01-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-04-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-07-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}